Charles River Laboratories International (CRL) Treasury Shares (2009 - 2025)

Charles River Laboratories International's Treasury Shares history runs 17 years deep, the most recent figure standing at $363.4 million for Q3 2025.

• In Q3 2025, Treasury Shares rose 203.82% year-over-year to $363.4 million; the TTM figure through Sep 2025 stood at $363.4 million (up 203.82% YoY), while the FY2018 annual figure was $55000.0, down 100.0% from the prior year.
• Treasury Shares for Q3 2025 stood at $363.4 million, roughly flat from $363.3 million in the prior quarter.
• The five-year high for Treasury Shares was $2.1 million in Q2 2025, with the low at $42000.0 in Q1 2024.
• The 5-year median for Treasury Shares is $131500.0 (2021), against an average of $553375.0.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares slumped 50.82% in 2024, then jumped 3712.97% in 2025.
• Charles River Laboratories International's Treasury Shares stood at $40.4 million in 2021, then declined by 4.82% to $38.5 million in 2022, then tumbled by 37.61% to $24.0 million in 2023, then surged by 398.09% to $119.6 million in 2024, then surged by 203.82% to $363.4 million in 2025.
• Business Quant data shows CRL's Treasury Shares at $363.4 million in Q3 2025, $363.3 million in Q2 2025, and $356.6 million in Q1 2025.